Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493064 · ClinicalTrials.gov registry record · Phase 2
To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
A Phase 2 study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT00493064 is a Phase 2 study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 63 participants.
The verdict
NCT00493064, a Phase 2 study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Niacin, a B vitamin, may act as a vasodilator to encourage earlier formation of collateral blood vessels that may serve to bypass the obstructed vein in the eye. The topical steroid eye drops are aimed at reducing swelling in the retina, until the collateral vessels have a chance to develop.
Interventions
- DRUG Nicotinic acid
- DRUG Prednisolone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2006-10 |
| Est. Completion | 2016-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493064
The ClinicalTrials.gov registry entry for NCT00493064 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Medical Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotinic acid is the first listed.
NCT00493064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00493064 about?
NCT00493064 is a clinical study titled "To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions". The purpose of this study is to determine whether Niacin, a B vitamin, may act as a vasodilator to encourage earlier formation of collateral blood vessels that may serve to bypass the obstructed vein in the eye. The topical steroid eye drops are aimed at reducing swelling in the retina, until the co...
What is the current status of trial NCT00493064?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2006-10. Estimated completion is 2016-10.
What interventions are being tested in trial NCT00493064?
The interventions under investigation include: Nicotinic acid (DRUG), Prednisolone acetate (DRUG).
Who is sponsoring clinical trial NCT00493064?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.